Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs

Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs

Manufacturing has been the key factor limiting rollout of vaccination during the COVID-19 pandemic, requiring rapid development and large-scale implementation of novel manufacturing technologies. ChAdOx1 nCoV-19 (AZD1222, Vaxzevria) is an efficacious vaccine against SARS-CoV-2, based upon an adenovi...

Full description

Bibliographic Details
Main Authors: Joe, CCD, Jiang, J, Linke, T, Li, Y, Fedosyuk, S, Gupta, G, Berg, A, Segireddy, RR, Mainwaring, D, Joshi, A, Cashen, P, Rees, B, Chopra, N, Nestola, P, Humphreys, J, Davies, S, Smith, N, Bruce, S, Verbart, D, Bormans, D, Knevelman, C, Woodyer, M, Davies, L, Cooper, L, Kapanidou, M, Bleckwenn, N, Pappas, D, Lambe, T, Smith, DC, Green, CM, Venkat, R, Ritchie, AJ, Gilbert, SC, Turner, R, Douglas, AD
Format: Journal article
Language:English
Published: Wiley 2021

Similar Items